Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by HighTower Advisors LLC

HighTower Advisors LLC lessened its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 12.7% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 12,641 shares of the company’s stock after selling 1,844 shares during the period. HighTower Advisors LLC’s holdings in Henry Schein were worth $921,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in HSIC. ING Groep NV acquired a new position in shares of Henry Schein in the third quarter valued at approximately $63,226,000. Holocene Advisors LP acquired a new position in Henry Schein in the 3rd quarter valued at $58,319,000. Thompson Siegel & Walmsley LLC purchased a new position in Henry Schein during the 2nd quarter worth $46,683,000. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in shares of Henry Schein in the 3rd quarter worth $43,740,000. Finally, Southpoint Capital Advisors LP boosted its holdings in shares of Henry Schein by 30.0% in the third quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock valued at $189,540,000 after acquiring an additional 600,000 shares in the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Trading Down 2.6 %

NASDAQ:HSIC opened at $73.18 on Wednesday. Henry Schein, Inc. has a 52-week low of $63.67 and a 52-week high of $82.63. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The stock has a fifty day simple moving average of $72.36 and a 200-day simple moving average of $70.10. The company has a market capitalization of $9.12 billion, a PE ratio of 30.12, a price-to-earnings-growth ratio of 2.31 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. The company had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm’s quarterly revenue was up .4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.32 earnings per share. On average, equities research analysts expect that Henry Schein, Inc. will post 4.78 earnings per share for the current fiscal year.

Analyst Ratings Changes

HSIC has been the subject of a number of recent analyst reports. Barrington Research restated an “outperform” rating and issued a $82.00 price objective on shares of Henry Schein in a research report on Wednesday, November 6th. Mizuho assumed coverage on Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price target for the company. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Finally, Evercore ISI raised their target price on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. Seven equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $78.89.

Insider Activity at Henry Schein

In related news, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares in the company, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.14% of the stock is owned by corporate insiders.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.